首页 | 本学科首页   官方微博 | 高级检索  
     

铁对白细胞介素-2舒血管效应的调制作用
引用本文:王琳琳,夏强,金红峰,陈莹莹,单绮娴,沈婷,孙勇,沈岳良. 铁对白细胞介素-2舒血管效应的调制作用[J]. 浙江大学学报(医学版), 2003, 32(3): 197-201,206
作者姓名:王琳琳  夏强  金红峰  陈莹莹  单绮娴  沈婷  孙勇  沈岳良
作者单位:浙江大学医学院生理学教研室,浙江,杭州,310031
基金项目:浙江省自然科学基金青年人才专项资金,浙江大学医学院中青年科研启动基金资助
摘    要:目的 :研究微量元素铁对白细胞介素 - 2 (IL- 2 )舒血管效应的调制作用及其机理。方法 :采用离体主动脉环灌流模型 ,在苯肾上腺素 (1μmol/ L)预收缩基础上 ,测定经柠檬酸铁胺 (FAC)处理后 IL- 2对血管张力的变化 ;用分光光度法测定血管一氧化氮合酶 (NOS)活性。结果 :FAC(0 .1~ 10μmol/ L )孵育 30 min后对血管的张力无影响 ,却能浓度依赖性的抑制 IL - 2 (1~ 10 0 0 U/ ml)的舒血管效应 (P<0 .0 5~ 0 .0 1)。 IL - 2 (1、10、10 0、10 0 0 U/ ml)单独作用后的血管张力分别为加药前的 (78.4 7± 4 .31) %、(6 6 .86± 5 .5 5 ) %、(5 2 .6 2± 4 .5 1) %和 (4 2 .39± 4 .2 7) %。10 μmol/ L FAC预处理后再加 IL- 2 ,血管张力为 (89.81± 1.94 ) %、(86 .13± 3.11) %、(77.16± 5 .6 6 ) %和 (6 8.76± 5 .6 9) %。L-精氨酸 (1mmol/ L)孵育取消了 FAC对 IL- 2舒血管效应的抑制作用。IL- 2 (10 0 0 U/ ml)使 NOS的活性从 (9.86± 0 .5 4) U/ ml prot显著增高为 (2 2 .10± 1.87) U/ ml prot。FAC(10 μmol/ L)单独孵育 30 min NOS的活性为 (10 .5 9± 0 .5 9) U/ ml prot,但是 FAC预处理再加 IL - 2后 ,NOS活性显著降低为 (15 .71± 0 .89) U/ ml prot;高钙 (2 .5 mmol/ L )预处理 ,不改变 FAC对

关 键 词:白细胞介素-2 舒血管效应 铁 调制作用 微量元素 苯肾上腺素 柠檬酸铁胺 胸主动脉
文章编号:1008-9292(2003)03-0197-05

Modulation of iron on the vasodilating effect of interleukin-2 in the isolated aortic ring
WANG Lin-lin,XIA Qiang,JIN Hong-feng,et al. Modulation of iron on the vasodilating effect of interleukin-2 in the isolated aortic ring[J]. Journal of Zhejiang University. Medical sciences, 2003, 32(3): 197-201,206
Authors:WANG Lin-lin  XIA Qiang  JIN Hong-feng  et al
Affiliation:Department of Physiology, College of Medical Sciences, Zhejiang University, Hangzhou 310031, China.
Abstract:OBJECTIVE: To explore the effect and mechanism of iron on the vasodilating effect of interleukin-2 (IL-2) in the isolated aortic ring. METHODS: Isometric tension was recorded in response to drugs in organ bath. Ferric ammonium citrate (FAC) was added to the bath 30 min before phenylephrine (1 micromol/L), which was followed by IL-2 in a cumulative fashion. Spectrophotometry was used to determine the activity of nitric oxide synthase (NOS) of the thoracic aorta. RESULTS: FAC (0.1 - 10 micromol/L) alone did not affect the tension of rings,but inhibited the vasodilating effect of IL-2 (1 - 1,000 U/ml) in a dose dependent manner. IL-2(1, 10, 100, 1000 U/ml) decreased the aortic tension to (78.47+/-4.31)%, (66.86+/-5.55)%, (52.62+/-4.51)% and (42.39+/-4.27)% of pre-drug control, respectively. However, after incubation with 10 micromol/L FAC in the presence of IL-2, the aortic tension was reduced to (89.81+/-1.94)%, (86.13+/-3.11)%, (77.16+/-5.66)% and (68.76+/-5.69)% of pre-drug control, respectively. Pretreatment with L-arginine (1 mmol/L) abolished the inhibitory effect of FAC. Pretreatment with FAC attenuated the increased activity of NOS induced by IL-2 from (22.10+/-1.87)U/mg prot to (15.71+/-0.89)U/mg prot. High Ca(2+) (2.5 mmol/L) incubation did not change the inhibitory effect of FAC. Pretreatment with FAC attenuated the increased caffeine-releasable pool of Ca(2+) by IL-2. High K(+) (10 mmol/L) incubation abolished the inhibitory effect of FAC. CONCLUSION: FAC inhibits the vasodilating effect of IL-2 in the isolated aortic ring,which may be mediated by decreasing the activity of NOS. Intracellular calcium release and inward rectifier potassium channel are involved in the inhibitory effect of FAC.
Keywords:Interleukin-2  Iron  Thoracic aorta
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号